Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-18

Clinical Trial Update: Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating daily co-trimoxazole prophylaxis to prevent malaria in pregnancy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Co-trimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Malaria in Pregnancy | Phase 3 | Status: TERMINATED